“This is the second expansion of the EVOLUTE family of resin-based, solid-phase extraction products, demonstrating our continued commitment to delivering high-quality solutions to our customers” says Scott Carr, Vice President of Commercial Operations for Biotage.
EVOLUTE WCX is a mixed-mode weak cation exchanger, developed for extraction of strongly basic analytes and quaternary amines from aqueous samples. These analytes are typically found in pesticides and provide analytical scientists with the ability to extract pesticides from diverse matrices, ranging from ground water to blood samples.
The resin-based sorbent is surface modified with well defined hydroxyl-functional oligomers, imparting excellent water wettability. An optimised combination of non-polar (hydrophobic), polar (hydrophilic) and cation exchange interactions allows efficient extraction of strongly basic analytes of wide ranging polarities and quaternary amines, allowing for up to 50% more efficient recoveries of pesticide residues. The non-polar/cation exchange dual retention mechanism allows the use of a rigorous interference regime, providing extremely clean extracts and reducing matrix effects associated with LC-MS/MS analysis.
Biotage is a global technology based company, providing tools for life science research. The company offers a broad range of solutions, knowledge and experience in the areas of analytical and medicinal chemistry. Customers include the world’s top 30 pharmaceutical companies, the world’s top 20 biotech companies, and leading academic institutes. The company is headquartered in Uppsala, Sweden and has subsidiaries in the United States, United Kingdom and Japan. Biotage has 270 employees with sales of SEK 394,1m in 2009. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange.